Exact Mass: 596.246879
Exact Mass Matches: 596.246879
Found 88 metabolites which its exact mass value is equals to given mass value 596.246879
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tetragastrin
Tetragastrin is the C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin. [HMDB] Tetragastrin is the C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005755 - Gastrins Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3]. Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3].
(7S*,8R*,7S*,8R*)-4,4-dimethoxyhuazhongilexin 9-O-alpha-L-arabinopyranoside
3-hydroxy-4,5-dimethoxyphenyl 6-O-{(2E,4E)-5-[(1R,3S,5R,8S)-3,8-dihydroxy-1,5-dimethyl-6-oxabixyclo[3.2.1.]oct-8-yl]-3-methyl-1-oxopenta-2,4-dien-1-yl}-alpha-L-glucopyranoside|thorelinin
(+)-4-O-methyllyoniresin-4-yl beta-D-glucopyranoside
Hexa-Me ether-(R)-2,4,7-Trihydroxy-3-(2,4,7-trihydroxyisoflavan-6-yl)flav-2-ene
Phe His Met Tyr
Phe His Tyr Met
Phe Met His Tyr
Phe Met Asn Trp
Phe Met Trp Asn
Phe Met Tyr His
Phe Asn Met Trp
Phe Asn Trp Met
Phe Trp Met Asn
Phe Trp Asn Met
Phe Tyr His Met
Phe Tyr Met His
His Phe Met Tyr
His Phe Tyr Met
His Met Phe Tyr
His Met Tyr Phe
His Tyr Phe Met
His Tyr Met Phe
Met Phe His Tyr
Met Phe Asn Trp
Met Phe Trp Asn
Met Phe Tyr His
Met His Phe Tyr
Met His Tyr Phe
Met Asn Phe Trp
Met Asn Trp Phe
Met Trp Phe Asn
Met Trp Asn Phe
Met Tyr Phe His
Met Tyr His Phe
Asn Phe Met Trp
Asn Phe Trp Met
Asn Met Phe Trp
Asn Met Trp Phe
Asn Trp Phe Met
Asn Trp Met Phe
Trp Phe Met Asn
Trp Phe Asn Met
Trp Met Phe Asn
Trp Met Asn Phe
Trp Asn Phe Met
Trp Asn Met Phe
Tyr Phe His Met
Tyr Phe Met His
Tyr His Phe Met
Tyr His Met Phe
Tyr Met Phe His
Tyr Met His Phe
CCK-4
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005755 - Gastrins Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3]. Tetragastrin (Cholecystokinin tetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin. Tetragastrin can stimulate gastric secretion[1]. Tetragastrin is a Cholecystokinin (CCK-4) receptor agonist[2]. Gastric mucosal protection[3].
Trimetaphan camsylate
C32H40N2O5S2 (596.2378510000001)
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
H-Tyr-Arg-Gly-Asp-Ser-OH trifluoroacetate salt
YRGDS Fibronectin Fragment is a fibronectin fragment, an adhesion peptide that displays strong binding affinity to thrombin-stimulated platelets[1].
Trimethaphan Camsylate
C32H40N2O5S2 (596.2378510000001)
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
[(4R,5R)-4-[[2-(azidomethyl)phenyl]methyl]-5-(2-azidophenyl)-2-[4-(3-hydroxypropoxy)phenyl]-5H-oxazol-4-yl]-(4-morpholinyl)methanone
C31H32N8O5 (596.2495541999999)
Tetragastrin
A tetrapeptide composed of L-tryptophan, L-methione, L-aspartic acid and L-phenylalaninamide residues joined in sequence.
(5ar,11s,11ar,12r)-1,3,4,6,8,9-hexamethoxy-11-phenyl-12-[(1e)-2-phenylethenyl]-5a,11,11a,12-tetrahydro-5,10-dioxatetraphene
methyl 2,12,14,16-tetrakis(acetyloxy)-3-hydroxy-4,13,17-trimethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-ene-9-carboxylate
2-{[6,7-bis(hydroxymethyl)-1,3-dimethoxy-8-(3,4,5-trimethoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
[3,4,5-trihydroxy-6-(3-hydroxy-4,5-dimethoxyphenoxy)oxan-2-yl]methyl 5-{3,8-dihydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-8-yl}-3-methylpenta-2,4-dienoate
4-(3-{3,4-dihydroxy-5-[3-(prop-2-en-1-yl)phenoxy]phenyl}-2,3-dihydroxypropyl)-5-(prop-2-en-1-yl)-3-[4-(prop-2-en-1-yl)phenoxy]benzene-1,2-diol
(2s,3r,4s,5s,6r)-2-{[(6r,7r,8s)-6,7-bis(hydroxymethyl)-1,3-dimethoxy-8-(3,4,5-trimethoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(5ar,11s,11ar,12s)-1,3,4,6,8,9-hexamethoxy-11-phenyl-12-[(1e)-2-phenylethenyl]-5a,11,11a,12-tetrahydro-5,10-dioxatetraphene
(5ar,6s,9r,9ar)-9-{[(5ar,6s,9r,9ar)-9-(chloromethyl)-9-hydroxy-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carbonyloxy]methyl}-9-hydroxy-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid
C30H41ClO10 (596.2388116000001)
4-(3-{3,4-dihydroxy-5-[4-(prop-2-en-1-yl)phenoxy]phenyl}-2,3-dihydroxypropyl)-5-(prop-2-en-1-yl)-3-[4-(prop-2-en-1-yl)phenoxy]benzene-1,2-diol
methyl (1s,2r,3s,4r,7s,8e,12r,13s,14s,16r,17r)-2,12,14,16-tetrakis(acetyloxy)-3-hydroxy-4,13,17-trimethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadec-8-ene-9-carboxylate
4-[(2r,3r)-3-{3,4-dihydroxy-5-[4-(prop-2-en-1-yl)phenoxy]phenyl}-2,3-dihydroxypropyl]-5-(prop-2-en-1-yl)-3-[4-(prop-2-en-1-yl)phenoxy]benzene-1,2-diol
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(3-hydroxy-4,5-dimethoxyphenoxy)oxan-2-yl]methyl (2e,4e)-5-[(1s,3s,5s,8s)-3,8-dihydroxy-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-8-yl]-3-methylpenta-2,4-dienoate
(1s,2s,3r,4r,7r,8s,10z,12s,13s,14r,16s,17s,18r)-2-(acetyloxy)-12-(butanoyloxy)-8-chloro-3-hydroxy-4,13,18-trimethyl-9-methylidene-5-oxo-6,15-dioxatetracyclo[11.5.0.0³,⁷.0¹⁴,¹⁶]octadec-10-en-17-yl butanoate
C30H41ClO10 (596.2388116000001)
2',5',9',10'-tetrakis(acetyloxy)-1',7'-dihydroxy-12',15',15'-trimethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-13'-yl acetate
9-{[9-(chloromethyl)-9-hydroxy-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carbonyloxy]methyl}-9-hydroxy-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid
C30H41ClO10 (596.2388116000001)